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The following procedure was used to generate the Thr7Val mutant of TsrA. The singlestrand DNA ultramer T7V was amplified by polymerase chain reaction using the primers T7V-F and T7V-R (Table S5 ). The PCR product was cloned into pSC-B-amp/kan using the StrataClone Blunt PCR Cloning Kit (Agilent Technologies, La Jolla, CA). The plasmid encoding the expected Thr7Val mutation was confirmed by DNA sequencing and designated as pCL66 (Table S4) .
The fosmid int-3A10 is an integrative fosmid harboring the entire tsr biosynthetic gene cluster. 1 The fosmid int-3A100 is a derivative of int-3A10, in which the region of tsrA encoding the 17 amino acid structural peptide of TsrA is replaced by a dual-marker disruption cassette S3 consisting of chl R , a chloramphenicol resistance gene, and a levansucrase-encoding sacB gene. 1 The tsrA T7S and T7A mutants were amplified from pCL64 and pCL65 by PCR with primers SD2-F and SD2-R. The tsrA T7V mutant was amplified from pCL66 with primers T7V-F and T7V-R. The resulting PCR products were then used to replace the dual-marker cassette in int-3A100 by PCR-targeted gene replacement, 2,3 yielding three sucrose-tolerant fosmids: int-3A104, int-3A105 and int-3A106 (Table S4 ). The incorporated mutations in int-3A104 to int-3A106 were confirmed by DNA sequence analysis. Fosmids int-3A10 (encoding wild-type TsrA), int-3A104 (for TsrA Thr7Ser), int-3A105 (for TsrA Thr7Ala) and int-3A106 (for TsrA Thr7Val) were first transformed into E. coli ET12567/pUZ8002, and then introduced into S. laurentii NDS1 through intergeneric conjugation. Colonies resistant to apramycin were selected for fermentation analysis.
Evaluation of thiostrepton analog production by S. laurentii NDS1/int-3A104, S. laurentii NDS1/int-3A105 and S. laurentii NDS1/int-3A106. Growth of S. laurentii was performed as described previously. 4 After fermentation, the whole cell culture was extracted twice with an equal volume of chloroform. The chloroform layers were pooled and the solvent removed in vacuo. The solid residue from 100 mL of culture was dissolved in 4 mL of chloroform. Samples were analyzed by HPLC with a Phenomenex Luna C18(2) column (250 × 4.6 mm, 5 μm). The column was developed using a gradient of 0-100% acetonitrile in water over 30 min at a flow rate of 1 mL min -1 . Absorbance was monitored at 254 nm. Under these conditions, thiostrepton A elutes with a t R of about 23 min.
Purification and structural determination of thiostrepton Thr7Ala 3 and SL105-1 4.
Crude extract from S. laurentii NDS1/int-3A105 (10 L) culture was purified by HPLC with a Phenomenex Luna C18(2) RP-Aqueous semi-preparative column (250 x 10 mm, 5 μm) while monitoring absorbance at 254 nm. The column was first developed using a gradient of 0 to 70% acetonitrile in water over 30 min at a flow rate of 4.7 mL min -1 , and fractions containing thiostrepton Thr7Ala 3 and SL105-1 4 were collected separately for each fraction. Solvent was removed in vacuo for the two fractions. The solid residues were dissolved in chloroform for further HPLC purification. For purification of thiostrepton Thr7Ala 3, the column was developed with a gradient of acetonitrile in water at a flow rate of 4.7 mL min -1 as follows: 10 to 40% acetonitrile over 5 min, 40% acetonitrile for 5 min, 40 to 48% acetonitrile over 5 min, 48% acetonitrile for 5 min, 48 to 100% acetonitrile over 5 min, and finally 100% acetonitrile for 5 min. For the purification of SL105-1 4, the column was developed with a gradient of acetonitrile in water at a flow rate of 4. Purification of characterization of thiostrepton Thr7Val 5 and SL106-1 6. Crude extract from S. laurentii NDS1/int-3A106 (4 L) culture was purified by HPLC with a Phenomenex Luna C18(2) RP-Aqueous semi-preparative column (250 x 10 mm, 5 μm) while monitoring absorbance at 254 nm. The column was first developed using a gradient of 0 to 60% acetonitrile in water over 30 min at a flow rate of 4 mL min -1 , and fractions containing thiostrepton Thr7Val 5 and SL106-1 6 were collected separately. Solvent was removed in vacuo S4 for each fraction. The solid residues were dissolved in chloroform for further HPLC purification. Antibacterial activity of thiostrepton analogs. Minimum inhibitory concentrations (MICs) of thiostrepton analogs against indicator strains were determined following the liquid microdilution method described previously. 1 The indicator strains used in this study were methicillin-resistant Staphylococcus aureus ATCC 10537 (MRSA), vancomycin-resistant Enterococcus faecium ATCC 12952 (VRE), Bacillus sp. ATCC 27859 (Bacillus) and Escherichia coli ATCC 27856 (E. coli). Thiostrepton A 1, thiostrepton Thr7Ala 3 and thiostrepton Thr7Val 5 were prepared in DMSO and quantified by UV spectroscopy using an extinction coefficient at 280 nm of 0.027 cm -1 μM -1 . 5 SL105-1 4 was first quantified by NMR against a tetramethylsilane internal standard and then used to generate a calibration curve by HPLC, and the stock solution was finally prepared in DMSO. SL106-1 6 was quantified by HPLC against the SL105-1 5 standard and prepared in DMSO. The positive antibiotic control used for Bacillus, and VRE was chloramphenicol, whereas the positive control for MRSA was vancomycin. DMSO was used as the negative control in all assays. Cell growth was monitored by comparing the optical density at 600 nm at the time of treatment and after 18 h incubation at 37 °C. A difference in OD 600 was considered growth and the lowest concentration causing complete suppression of visible bacterial growth defined the MIC. (1) 
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Figure S10. gCOSY spectrum of thiostrepton Thr7Ala 3 (500 MHz, CDCl 3 -CD 3 OD 4:1, 25 °C).
Figure S11. gHSQC spectrum of thiostrepton Thr7Ala 3 (500 MHz, CDCl 3 -CD 3 OD 4:1, 25 °C).
Figure S12 Chemically synthesized ultramer to generate TsrA Thr7Val.
(B)
T7V-F T7V-R 5'-ACTACATGGACGAGACGCTGCTC-3' 5'-CAGGTCCGGCGGGCGGGGA-3'
Primers for amplification of chemically synthesized ultramer TsrA T7V. SD2-F 5'-GCGCGATCGACGCGACCGCAG-3' Primers used in the amplification of tsrA variants from pCL64 and pCL65. SD2-R 5'-GGCGGGGAGGAACAGTCCTCC-3' SD3-F 5'-ATCGTGTTGGGCTTGACG-3' Primers used in DNA sequencing to confirm int-3A104, int-3A105, and int-3A106. SD3-R 5'-CGCGGTGCAATAGGACAT-3'
